AMPLIRUN® Total Meningitis Control, 10 x 400 µL

The Vircell AMPLIRUN® Total Meningitis Control is a comprehensive external quality control designed for nucleic acid detection of the main viral, bacterial, and fungal pathogens that cause meningitis. Formulated in a matrix that mimics human cerebrospinal fluid (CSF), this control ensures realistic assay validation across the entire molecular workflow, from extraction to amplification and detection.

Each vial contains inactivated, quantified whole pathogens at low-positive concentrations to reflect clinically relevant levels. With a lyophilized presentation, this control provides long-term stability, simplified handling, and compatibility with multiple molecular platforms.

Available Control

Key Features

• Inactivated whole pathogens – contain complete genomes for maximum platform compatibility.
• CSF-mimicking matrix – formulated to replicate clinical cerebrospinal fluid samples.
• External quality control – validates extraction, amplification, and detection steps.
• Quantified, low-positive controls – prepared at clinically significant concentrations.
• Monodose lyophilized vials – 10 single-use vials ensure reproducibility and reduce contamination risk.
• Non-infectious material – supplied with inactivation certificate.
• Stable & transport-friendly – lyophilized format eliminates cold chain requirements.

Applications

• External quality control for meningitis molecular assays (PCR/qPCR/NAATs).
• Validation and verification of in-house and commercial multiplex meningitis panels.
• Sensitivity, specificity, LoD, and reproducibility testing.
• Routine performance monitoring of laboratory workflows and reagent batches.
• Training, staff proficiency testing, and competency evaluation.
• Troubleshooting assay inconsistencies and failures.
• Supporting compliance with laboratory accreditation and regulatory standards.

Product Details

The AMPLIRUN® Total Meningitis Control provides laboratories with a reliable, standardized external QC panel for the molecular detection of meningitis pathogens. By combining inactivated viral, bacterial, and fungal agents in a CSF-like matrix, it ensures clinically relevant assay validation, quality assurance, and compliance with international laboratory accreditation requirements.